A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Clinical trial NCT05556512 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05556512
Sponsor: Eli Lilly and Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2022-10-11
Primary completion: 2027-10-01
Enrollment: 15374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.